Viewing 1 - 7 of 9 jobs
institutions: Genentech, Boehringer Ingelheim, Eisai/H3 Biomedicine, Novartis, Janssen, and TGEN, each leveraging FORMA's capabilities, capacity, and innovations. In 2011, FORMA was selected by Fierce Biotech as one of the top 15 most...
institutions: Genentech, Boehringer Ingelheim, Eisai/H3 Biomedicine, Novartis, Janssen, and TGEN, each leveraging FORMA's capabilities, capacity, and innovations. In 2011, FORMA was selected by Fierce Biotech as one of the top 15 most...
institutions: Genentech, BoehringerIngelheim, Eisai/H3 Biomedicine, Novartis, Janssen, and TGEN, each leveraging FORMA's capabilities, capacity, and innovations. In 2011, FORMA was selected by Fierce Biotech as one of the top 15 most...
institutions: Genentech, BoehringerIngelheim, Eisai/H3 Biomedicine, Novartis, Janssen, and TGEN, each leveraging FORMA's capabilities, capacity, and innovations. In 2011, FORMA was selected by Fierce Biotech as one of the top 15 most...
institutions: Genentech, Boehringer Ingelheim, Eisai/H3 Biomedicine, Novartis, Janssen, and TGEN, each leveraging FORMA's capabilities, capacity, and innovations. In 2011, FORMA was selected by Fierce Biotech as one of the top 15 most...
institutions: Genentech, Boehringer Ingelheim, Eisai/H3 Biomedicine, Novartis, Janssen, and TGEN, each leveraging FORMA's capabilities, capacity, and innovations. In 2011, FORMA was selected by Fierce Biotech as one of the top 15 most...
institutions: Genentech, Boehringer Ingelheim, Eisai/H3 Biomedicine, Novartis, Janssen, and TGEN, each leveraging FORMA's capabilities, capacity, and innovations. In 2011, FORMA was selected by Fierce Biotech as one of the top 15 most...
To further refine your results, please use the advanced filters below.